Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia. (Q54479075)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia. |
scientific article |
Statements
Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia (English)
Lesley J Ashton
Nicola C Venn
Jodie E Giles
Anita Y Bahar
Rosemary Sutton
Jonathan Tolisano
Lochie Teague
Gemma Rigutto
Keith Waters
Glenn M Marshall
Australian and New Zealand Children's Oncology Group